Cerecor Inc (NASDAQ:CERC) Director Armistice Capital, Llc bought 12,651 shares of the firm’s stock in a transaction dated Friday, January 11th. The shares were acquired at an average price of $3.90 per share, for a total transaction of $49,338.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Armistice Capital, Llc also recently made the following trade(s):

  • On Wednesday, January 9th, Armistice Capital, Llc bought 545 shares of Cerecor stock. The shares were acquired at an average price of $3.79 per share, for a total transaction of $2,065.55.
  • On Monday, January 7th, Armistice Capital, Llc bought 6,504 shares of Cerecor stock. The shares were acquired at an average price of $3.65 per share, for a total transaction of $23,739.60.
  • On Friday, January 4th, Armistice Capital, Llc bought 20,000 shares of Cerecor stock. The shares were acquired at an average price of $3.42 per share, for a total transaction of $68,400.00.
  • On Tuesday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The shares were acquired at an average price of $3.18 per share, for a total transaction of $39,114.00.
  • On Saturday, December 28th, Armistice Capital, Llc bought 26,499 shares of Cerecor stock. The shares were acquired at an average price of $3.12 per share, for a total transaction of $82,676.88.
  • On Monday, December 31st, Armistice Capital, Llc bought 12,300 shares of Cerecor stock. The shares were acquired at an average price of $3.18 per share, for a total transaction of $39,114.00.
  • On Friday, December 28th, Armistice Capital, Llc bought 26,499 shares of Cerecor stock. The shares were acquired at an average price of $3.12 per share, for a total transaction of $82,676.88.
  • On Monday, December 17th, Armistice Capital, Llc bought 14,938 shares of Cerecor stock. The shares were acquired at an average price of $3.26 per share, for a total transaction of $48,697.88.
  • On Friday, December 14th, Armistice Capital, Llc bought 28,032 shares of Cerecor stock. The shares were acquired at an average price of $3.33 per share, for a total transaction of $93,346.56.
  • On Monday, December 10th, Armistice Capital, Llc bought 13,815 shares of Cerecor stock. The shares were acquired at an average price of $3.36 per share, for a total transaction of $46,418.40.

Cerecor stock traded up $0.01 during midday trading on Friday, reaching $3.90. The stock had a trading volume of 20,155 shares, compared to its average volume of 44,688. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.70. Cerecor Inc has a 52-week low of $2.36 and a 52-week high of $5.74. The firm has a market capitalization of $154.25 million, a P/E ratio of 9.29 and a beta of 1.30.

Cerecor (NASDAQ:CERC) last posted its quarterly earnings data on Tuesday, November 13th. The company reported ($0.26) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.14). Cerecor had a negative return on equity of 75.94% and a negative net margin of 241.29%. The firm had revenue of $4.08 million during the quarter, compared to analysts’ expectations of $4.80 million. Research analysts anticipate that Cerecor Inc will post -1.09 earnings per share for the current fiscal year.

Institutional investors have recently bought and sold shares of the stock. BlackRock Inc. raised its position in Cerecor by 630.4% in the 2nd quarter. BlackRock Inc. now owns 27,520 shares of the company’s stock worth $120,000 after purchasing an additional 23,752 shares during the period. Cambridge Investment Research Advisors Inc. purchased a new stake in Cerecor in the 3rd quarter worth about $169,000. Finally, Vanguard Group Inc raised its position in Cerecor by 10.1% in the 3rd quarter. Vanguard Group Inc now owns 87,929 shares of the company’s stock worth $411,000 after purchasing an additional 8,094 shares during the period. 44.48% of the stock is currently owned by institutional investors.

Several analysts have recently issued reports on CERC shares. LADENBURG THALM/SH SH started coverage on shares of Cerecor in a research report on Thursday, December 20th. They set a “buy” rating and a $9.00 target price on the stock. TheStreet cut shares of Cerecor from a “c” rating to a “d” rating in a research report on Monday, December 17th. Finally, ValuEngine upgraded shares of Cerecor from a “hold” rating to a “buy” rating in a research report on Thursday, November 1st.

TRADEMARK VIOLATION WARNING: “Insider Buying: Cerecor Inc (CERC) Director Buys 12,651 Shares of Stock” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this news story can be read at https://www.dailypolitical.com/2019/01/12/insider-buying-cerecor-inc-cerc-director-buys-12651-shares-of-stock.html.

About Cerecor

Cerecor Inc, a pharmaceutical company, focuses on pediatric health care. Its lead product portfolio includes prescribed dietary supplements, such as Poly-Vi-Flor and Tri-Vi-Flor; and prescription drugs, such as Millipre, Veripred, and Ulesfia for the treatment of inflammation of the skin, joints, lungs, and other organs, as well as asthma, allergies, arthritis, and head lice infestation.

Recommended Story: Why Dividend Stocks May Be Right for You

Insider Buying and Selling by Quarter for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.